fda warning bpc-157 not approved peptide panel backs compounded BPC-157, KPV peptides in win for RFK Jr An FDA panel on Friday

Research conducted on rats showed that this synthetic peptide can counteract the effects of cuprizone, a drug that induces demyelination of nerve fibers and mimic the damage caused by multiple sclerosis, by reducing nerve damage [10]

The convenience factor is significant

The regulatory and legal status of BPC-157 is that of an unapproved research compound in the United States and in most global jurisdictions, with no marketing authorization from any major regulatory agency for human therapeutic use

From a 10 mg vial (5 mg/mL) that is 0.5 mL = 50 units

Use our free online tool to explore treatments and therapies on your own

Whether you're dealing with old injuries, want to bounce back quicker after a tough workout, or just want to support your overall health, I cant recommend this peptide enough